Derek Archila Score: 22
Analyst at
Wells Fargo
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
-5.9%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
45%
20 W / 24 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
42%
10 W / 14 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 24 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 24 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
41%
13 W / 19 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
46%
17 W / 20 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
43%
3 W / 4 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| May 13, 2026 |
Celldex Therapeutics Inc.
CLDX
|
BUY |
$54.00
Est. +69%
|
$32.00 | $33.08 |
Pending
|
$32.12
+0.4%
|
| Jan 29, 2026 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$29.00
Est. +62%
|
$17.87 | $19.32 |
Pending
|
$17.04
-4.6%
|
| Jan 20, 2026 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$330.00
Est. +60%
|
$205.83 | $250.74 |
Pending
|
$223.29
+8.5%
|
| Jan 20, 2026 |
Rhythm Pharmaceuticals Inc.
RYTM
|
BUY |
$145.00
Est. +43%
|
$101.63 | $110.93 |
Pending
|
$89.70
-11.7%
|
| Jan 20, 2026 |
Soleno Therapeutics Inc
SLNO
|
BUY |
$114.00
Est. +168%
|
$42.48 | $53.01 |
Pending
|
$53.01
+24.8%
|
| Jan 06, 2026 |
Alumis Inc.
ALMS
|
BUY |
$39.00
Est. +130%
|
$16.97 | $30.51 |
Pending
|
$24.15
+42.3%
|
| Dec 09, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$116.00
Est. +23%
|
$94.30 | $103.00 |
Pending
|
$85.59
-9.2%
|
| Dec 08, 2025 |
Incyte Corp.
INCY
|
BUY |
$116.00
Est. +13%
|
$102.52 | $112.29 |
Pending
|
$101.98
-0.5%
|
| Nov 14, 2025 |
Septerna, Inc.
SEPN
|
BUY |
$28.00
Est. +46%
|
$19.24 | $36.26 |
Target Met
|
$35.95
+86.9%
|
| Nov 05, 2025 |
Soleno Therapeutics Inc
SLNO
|
BUY |
$106.00
Est. +66%
|
$63.85 | $55.47 |
Pending
|
$53.01
-17.0%
|
| Oct 29, 2025 |
Incyte Corp.
INCY
|
BUY |
$97.00
Est. +5%
|
$92.02 | $112.29 |
Target Met
|
$101.98
+10.8%
|
| Oct 21, 2025 |
Exelixis Inc
EXEL
|
SELL |
$30.00
Est. +13%
|
$34.54 | $34.64 (Low) |
Pending
|
$53.00
-53.4%
|
| Sep 23, 2025 |
C4 Therapeutics Inc
CCCC
|
BUY |
$10.00
Est. +257%
|
$2.80 | $4.60 |
Pending
|
$3.82
+36.4%
|
| Sep 15, 2025 |
Atyr Pharma Inc
ATYR
|
SELL |
$1.00
Est. +2%
|
$1.02 | $0.40 (Low) |
Target Met
|
$0.44
+56.8%
|
| May 16, 2025 |
Septerna, Inc.
SEPN
|
BUY |
$18.00
Est. +83%
|
$9.84 | $32.63 |
Target Met
|
$35.95
+265.3%
|
| Mar 12, 2025 |
Arvinas Inc
ARVN
|
BUY |
$26.00
Est. +213%
|
$8.30 | $16.14 |
Miss
|
$7.49
-9.8%
|
| Feb 18, 2025 |
Septerna, Inc.
SEPN
|
BUY |
$14.00
Est. +8%
|
$12.96 | $31.34 |
Target Met
|
$35.95
+177.4%
|
| Dec 19, 2024 |
C4 Therapeutics Inc
CCCC
|
BUY |
$12.00
Est. +178%
|
$4.31 | $4.26 |
Miss
|
$3.82
-11.4%
|
| Dec 19, 2024 |
Kezar Life Sciences Inc
KZR
|
BUY |
$9.00
Est. +44%
|
$6.26 | $6.95 |
Miss
|
$7.29
+16.5%
|
| Dec 02, 2024 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$57.00
Est. +17%
|
$48.54 | $68.80 |
Target Met
|
$85.59
+76.3%
|
| Nov 01, 2024 |
Zymeworks BC Inc
ZYME
|
SELL |
$12.00
Est. +10%
|
$13.28 | $9.04 (Low) |
Target Met
|
$23.26
-75.2%
|
| Oct 16, 2024 |
Acelyrin Inc
SLRN
|
BUY |
$15.00
Est. +162%
|
$5.72 | $6.52 |
Miss
|
$2.27
-60.3%
|
| Oct 15, 2024 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$32.00
Est. +27%
|
$25.16 | $29.56 |
Miss
|
$17.04
-32.3%
|
| Sep 25, 2024 |
Celldex Therapeutics Inc.
CLDX
|
BUY |
$44.00
Est. +22%
|
$36.02 | $47.00 |
Target Met
|
$32.12
-10.8%
|
| Sep 17, 2024 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$289.00
Est. +107%
|
$139.57 | $208.16 |
Miss
|
$223.29
+60.0%
|
| Sep 11, 2024 |
Q32 Bio Inc.
QTTB
|
BUY |
$95.00
Est. +88%
|
$50.61 | $53.73 |
Miss
|
$12.64
-75.0%
|
| Jun 24, 2024 |
Argen X SE - ADR
ARGX
|
BUY |
$542.00
Est. +37%
|
$394.47 | $678.21 |
Target Met
|
$884.20
+124.1%
|
| Jun 05, 2024 |
Annexon Inc
ANNX
|
BUY |
$14.00
Est. +134%
|
$5.99 | $7.85 |
Miss
|
$4.64
-22.5%
|
| May 23, 2024 |
Apellis Pharmaceuticals Inc
APLS
|
BUY |
$48.00
Est. +10%
|
$43.60 | $42.47 |
Miss
|
$41.03
-5.9%
|
| May 15, 2024 |
Annexon Inc
ANNX
|
BUY |
$10.00
Est. +107%
|
$4.82 | $7.85 |
Miss
|
$4.64
-3.7%
|
| Apr 01, 2024 |
Annexon Inc
ANNX
|
BUY |
$12.00
Est. +67%
|
$7.17 | $7.85 |
Miss
|
$4.64
-35.3%
|
| Mar 20, 2024 |
Acelyrin Inc
SLRN
|
BUY |
$13.00
Est. +56%
|
$8.32 | $7.25 |
Miss
|
$2.27
-72.7%
|
| Mar 12, 2024 |
Ventyx Biosciences Inc
VTYX
|
BUY |
$16.00
Est. +90%
|
$8.42 | $3.39 |
Miss
|
$14.00
+66.3%
|
| Dec 19, 2023 |
Arvinas Inc
ARVN
|
BUY |
$63.00
Est. +66%
|
$37.87 | $34.09 |
Miss
|
$7.49
-80.2%
|
| Nov 10, 2023 |
Celldex Therapeutics Inc.
CLDX
|
BUY |
$27.00
Est. +5%
|
$25.78 | $47.00 |
Target Met
|
$32.12
+24.6%
|
| Jan 02, 2023 |
Apellis Pharmaceuticals Inc
APLS
|
BUY |
$58.00
Est. +12%
|
$51.71 | - | - |
$41.03
-20.7%
|
| Aug 17, 2022 |
Blueprint Medicines Corp
BPMC
|
SELL |
$41.00
Est. +22%
|
$52.78 | - | - |
$129.46
-145.3%
|
| May 31, 2022 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$25.00
Est. +148%
|
$10.09 | - | - |
$17.04
+68.9%
|
| Feb 09, 2022 |
Arvinas Inc
ARVN
|
BUY |
$98.00
Est. +31%
|
$74.68 | - | - |
$7.49
-90.0%
|
| Dec 06, 2021 |
Canopy Growth Corporation
CGC
|
SELL |
$8.00
Est. +21%
|
$10.15 | - | - |
$0.98
+90.3%
|
| May 09, 2021 |
Galapagos NV - ADR
GLPG
|
BUY |
$97.00
Est. +32%
|
$73.54 | - | - |
$27.98
-62.0%
|
| May 06, 2021 |
Madrigal Pharmaceuticals Inc
MDGL
|
BUY |
$130.00
Est. +3%
|
$126.71 | - | - |
$499.76
+294.4%
|
| May 06, 2021 |
Intercept Pharmaceuticals Inc
ICPT
|
SELL |
$16.00
Est. +6%
|
$17.01 | - | - |
$19.00
-11.7%
|
| May 04, 2021 |
Esperion Therapeutics Inc.
ESPR
|
SELL |
$20.00
Est. +22%
|
$25.59 | - | - |
$3.15
+87.7%
|
Celldex Therapeutics Inc.
CLDX
May 13, 2026
Signal & Target
BUY
$54.00
Start Price
$32.00
Best Price (1Y)
$33.08
Current Price
$32.12
Return
+0.4%
Nurix Therapeutics Inc
NRIX
Jan 29, 2026
Signal & Target
BUY
$29.00
Start Price
$17.87
Best Price (1Y)
$19.32
Current Price
$17.04
Return
-4.6%
Ascendis Pharma A/S - ADR
ASND
Jan 20, 2026
Signal & Target
BUY
$330.00
Start Price
$205.83
Best Price (1Y)
$250.74
Current Price
$223.29
Return
+8.5%
Rhythm Pharmaceuticals Inc.
RYTM
Jan 20, 2026
Signal & Target
BUY
$145.00
Start Price
$101.63
Best Price (1Y)
$110.93
Current Price
$89.70
Return
-11.7%
Soleno Therapeutics Inc
SLNO
Jan 20, 2026
Signal & Target
BUY
$114.00
Start Price
$42.48
Best Price (1Y)
$53.01
Current Price
$53.01
Return
+24.8%
Alumis Inc.
ALMS
Jan 06, 2026
Signal & Target
BUY
$39.00
Start Price
$16.97
Best Price (1Y)
$30.51
Current Price
$24.15
Return
+42.3%
Kymera Therapeutics Inc
KYMR
Dec 09, 2025
Signal & Target
BUY
$116.00
Start Price
$94.30
Best Price (1Y)
$103.00
Current Price
$85.59
Return
-9.2%
Incyte Corp.
INCY
Dec 08, 2025
Signal & Target
BUY
$116.00
Start Price
$102.52
Best Price (1Y)
$112.29
Current Price
$101.98
Return
-0.5%
Septerna, Inc.
SEPN
Nov 14, 2025
Signal & Target
BUY
$28.00
Start Price
$19.24
Best Price (1Y)
$36.26
Current Price
$35.95
Return
+86.9%
Soleno Therapeutics Inc
SLNO
Nov 05, 2025
Signal & Target
BUY
$106.00
Start Price
$63.85
Best Price (1Y)
$55.47
Current Price
$53.01
Return
-17.0%
Incyte Corp.
INCY
Oct 29, 2025
Signal & Target
BUY
$97.00
Start Price
$92.02
Best Price (1Y)
$112.29
Current Price
$101.98
Return
+10.8%
Exelixis Inc
EXEL
Oct 21, 2025
Signal & Target
SELL
$30.00
Start Price
$34.54
Best Price (1Y)
$34.64
Current Price
$53.00
Return
-53.4%
C4 Therapeutics Inc
CCCC
Sep 23, 2025
Signal & Target
BUY
$10.00
Start Price
$2.80
Best Price (1Y)
$4.60
Current Price
$3.82
Return
+36.4%
Atyr Pharma Inc
ATYR
Sep 15, 2025
Signal & Target
SELL
$1.00
Start Price
$1.02
Best Price (1Y)
$0.40
Current Price
$0.44
Return
+56.8%
Septerna, Inc.
SEPN
May 16, 2025
Signal & Target
BUY
$18.00
Start Price
$9.84
Best Price (1Y)
$32.63
Current Price
$35.95
Return
+265.3%
Arvinas Inc
ARVN
Mar 12, 2025
Signal & Target
BUY
$26.00
Start Price
$8.30
Best Price (1Y)
$16.14
Current Price
$7.49
Return
-9.8%
Septerna, Inc.
SEPN
Feb 18, 2025
Signal & Target
BUY
$14.00
Start Price
$12.96
Best Price (1Y)
$31.34
Current Price
$35.95
Return
+177.4%
C4 Therapeutics Inc
CCCC
Dec 19, 2024
Signal & Target
BUY
$12.00
Start Price
$4.31
Best Price (1Y)
$4.26
Current Price
$3.82
Return
-11.4%
Kezar Life Sciences Inc
KZR
Dec 19, 2024
Signal & Target
BUY
$9.00
Start Price
$6.26
Best Price (1Y)
$6.95
Current Price
$7.29
Return
+16.5%
Kymera Therapeutics Inc
KYMR
Dec 02, 2024
Signal & Target
BUY
$57.00
Start Price
$48.54
Best Price (1Y)
$68.80
Current Price
$85.59
Return
+76.3%
Zymeworks BC Inc
ZYME
Nov 01, 2024
Signal & Target
SELL
$12.00
Start Price
$13.28
Best Price (1Y)
$9.04
Current Price
$23.26
Return
-75.2%
Acelyrin Inc
SLRN
Oct 16, 2024
Signal & Target
BUY
$15.00
Start Price
$5.72
Best Price (1Y)
$6.52
Current Price
$2.27
Return
-60.3%
Nurix Therapeutics Inc
NRIX
Oct 15, 2024
Signal & Target
BUY
$32.00
Start Price
$25.16
Best Price (1Y)
$29.56
Current Price
$17.04
Return
-32.3%
Celldex Therapeutics Inc.
CLDX
Sep 25, 2024
Signal & Target
BUY
$44.00
Start Price
$36.02
Best Price (1Y)
$47.00
Current Price
$32.12
Return
-10.8%
Ascendis Pharma A/S - ADR
ASND
Sep 17, 2024
Signal & Target
BUY
$289.00
Start Price
$139.57
Best Price (1Y)
$208.16
Current Price
$223.29
Return
+60.0%
Q32 Bio Inc.
QTTB
Sep 11, 2024
Signal & Target
BUY
$95.00
Start Price
$50.61
Best Price (1Y)
$53.73
Current Price
$12.64
Return
-75.0%
Argen X SE - ADR
ARGX
Jun 24, 2024
Signal & Target
BUY
$542.00
Start Price
$394.47
Best Price (1Y)
$678.21
Current Price
$884.20
Return
+124.1%
Annexon Inc
ANNX
Jun 05, 2024
Signal & Target
BUY
$14.00
Start Price
$5.99
Best Price (1Y)
$7.85
Current Price
$4.64
Return
-22.5%
Apellis Pharmaceuticals Inc
APLS
May 23, 2024
Signal & Target
BUY
$48.00
Start Price
$43.60
Best Price (1Y)
$42.47
Current Price
$41.03
Return
-5.9%
Annexon Inc
ANNX
May 15, 2024
Signal & Target
BUY
$10.00
Start Price
$4.82
Best Price (1Y)
$7.85
Current Price
$4.64
Return
-3.7%
Annexon Inc
ANNX
Apr 01, 2024
Signal & Target
BUY
$12.00
Start Price
$7.17
Best Price (1Y)
$7.85
Current Price
$4.64
Return
-35.3%
Acelyrin Inc
SLRN
Mar 20, 2024
Signal & Target
BUY
$13.00
Start Price
$8.32
Best Price (1Y)
$7.25
Current Price
$2.27
Return
-72.7%
Ventyx Biosciences Inc
VTYX
Mar 12, 2024
Signal & Target
BUY
$16.00
Start Price
$8.42
Best Price (1Y)
$3.39
Current Price
$14.00
Return
+66.3%
Arvinas Inc
ARVN
Dec 19, 2023
Signal & Target
BUY
$63.00
Start Price
$37.87
Best Price (1Y)
$34.09
Current Price
$7.49
Return
-80.2%
Celldex Therapeutics Inc.
CLDX
Nov 10, 2023
Signal & Target
BUY
$27.00
Start Price
$25.78
Best Price (1Y)
$47.00
Current Price
$32.12
Return
+24.6%
Apellis Pharmaceuticals Inc
APLS
Jan 02, 2023
Signal & Target
BUY
$58.00
Start Price
$51.71
Best Price (1Y)
-
Current Price
$41.03
Return
-20.7%
Blueprint Medicines Corp
BPMC
Aug 17, 2022
Signal & Target
SELL
$41.00
Start Price
$52.78
Best Price (1Y)
-
Current Price
$129.46
Return
-145.3%
Nurix Therapeutics Inc
NRIX
May 31, 2022
Signal & Target
BUY
$25.00
Start Price
$10.09
Best Price (1Y)
-
Current Price
$17.04
Return
+68.9%
Arvinas Inc
ARVN
Feb 09, 2022
Signal & Target
BUY
$98.00
Start Price
$74.68
Best Price (1Y)
-
Current Price
$7.49
Return
-90.0%
Canopy Growth Corporation
CGC
Dec 06, 2021
Signal & Target
SELL
$8.00
Start Price
$10.15
Best Price (1Y)
-
Current Price
$0.98
Return
+90.3%
Galapagos NV - ADR
GLPG
May 09, 2021
Signal & Target
BUY
$97.00
Start Price
$73.54
Best Price (1Y)
-
Current Price
$27.98
Return
-62.0%
Madrigal Pharmaceuticals Inc
MDGL
May 06, 2021
Signal & Target
BUY
$130.00
Start Price
$126.71
Best Price (1Y)
-
Current Price
$499.76
Return
+294.4%
Intercept Pharmaceuticals Inc
ICPT
May 06, 2021
Signal & Target
SELL
$16.00
Start Price
$17.01
Best Price (1Y)
-
Current Price
$19.00
Return
-11.7%
Esperion Therapeutics Inc.
ESPR
May 04, 2021
Signal & Target
SELL
$20.00
Start Price
$25.59
Best Price (1Y)
-
Current Price
$3.15
Return
+87.7%